Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity Under Strategic Partnership With Pfizer

Flagship Pioneering and ProFound Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines for a...

PR NewswireJun 12 19:00

Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June

CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by

GlobeNewswireMay 28 19:00

Foghorn Therapeutics Raises ~$110 Million Through Direct Offering

Seeking AlphaMay 23 18:31

Foghorn Therapeutics raised approximately $110 million through registered direct offering to advance pipeline construction

Foghorn Therapeutics raised approximately $110 million through registered direct offering to advance pipeline construction

Zhitong FinanceMay 23 06:22

Foghorn Therapeutics Inc.: Deferring Cash Flow to 2027

Foghorn Therapeutics Inc.: Deferring Cash Flow to 2027

Zhitong FinanceMay 23 06:22

Express News | Foghorn Therapeutics Inc.: Extends Cash Runway Into 2027

BreakingsMay 23 06:21